[1]
I. . Hayat, T. . Sattar, S. Shafiq, H. M. Ejaz, and M. H. Noor, “Glycemic Outcomes of Oral Hypoglycemics Versus GLP-1 Receptor Agonists in Type 2 Diabetes: A Comparative Clinical Study: Oral Hypoglycemics Versus GLP-1 Agonists in Type 2 Diabetes Glycemic Control”, Dev. med. life sci., vol. 2, no. 10, pp. 23–28, Oct. 2025, doi: 10.69750/dmls.02.010.0168.